Follow
Javier Crespo
Javier Crespo
Jefe Servicio Digestivo. Hospital Universitario Marqués de Valdecilla. Profesor Titular Digestivo
Verified email at humv.es
Title
Cited by
Cited by
Year
Host recognition of bacterial muramyl dipeptide mediated through NOD2: implications for Crohn′ s disease
N Inohara, Y Ogura, A Fontalba, O Gutierrez, F Pons, J Crespo, K Fukase, ...
Journal of Biological Chemistry 278 (8), 5509-5512, 2003
21372003
Modeling nafld disease burden in china, france, germany, italy, japan, spain, united kingdom, and united states for the period 2016–2030
C Estes, QM Anstee, MT Arias-Loste, H Bantel, S Bellentani, J Caballeria, ...
Journal of hepatology 69 (4), 896-904, 2018
14822018
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening.
SA Ratziu V, Harrison S, Francque S, Bedossa P, Lehert P, Serfaty L, Romero ...
Gastroenterology, 2016
1093*2016
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ...
The Lancet 394 (10215), 2184-2196, 2019
10232019
Sofosbuvir and ribavirin in HCV genotypes 2 and 3.
ER Zeuzem S1, Dusheiko GM, Salupere R, Mangia A, Flisiak R, Hyland RH ...
N Engl J Med 370 (21), 1993-2001, 2014
1016*2014
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.
HSA Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal ...
New England Journal of Medicine 25 (384(12)), 1113-1124, 2021
993*2021
Gene expression of tumor necrosis factor [alpha] and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients
J Crespo, P Fern, M Hern, M Mayorga, F Pons-Romero
Hepatology 34 (6), 1158-1163, 2001
9212001
Adiponectin and its receptors in non-alcoholic steatohepatitis
S Kaser, A Moschen, A Cayon, A Kaser, J Crespo, F Pons-Romero, ...
Gut 54 (1), 117-121, 2005
5952005
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment
JM Sánchez–Tapias, M Diago, P Escartín, J Enríquez, M Romero–Gómez, ...
Gastroenterology 131 (2), 451-460, 2006
4692006
Advancing the global public health agenda for NAFLD: a consensus statement
JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ...
Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022
4052022
Vitamin D status in hospitalized patients with SARS-CoV-2 infection
JL Hernández, D Nan, M Fernandez-Ayala, M García-Unzueta, ...
The Journal of Clinical Endocrinology & Metabolism 106 (3), e1343-e1353, 2021
3282021
Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non …
A Guerra Ruiz, F Casafont, J Crespo, A Cayón, M Mayorga, A Estebanez, ...
Obesity surgery 17, 1374-1380, 2007
3242007
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
2852022
Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial
J de la Peña, E Brullet, E Sanchez‐Hernández, M Rivero, M Vergara, ...
Hepatology 41 (3), 572-578, 2005
2792005
Metabolomic identification of subtypes of nonalcoholic steatohepatitis
C Alonso, D Fernández-Ramos, M Varela-Rey, I Martínez-Arranz, ...
Gastroenterology 152 (6), 1449-1461. e7, 2017
2492017
Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression
J Barr, J Caballería, I Martínez-Arranz, A Domínguez-Díez, C Alonso, ...
Journal of proteome research 11 (4), 2521-2532, 2012
2392012
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis
SA Harrison, Z Goodman, A Jabbar, R Vemulapalli, ZH Younes, B Freilich, ...
Journal of hepatology 72 (5), 816-827, 2020
2152020
Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.
J Crespo, JL Lozano, F De La Cruz, L Rodrigo, M Rodriguez, ...
American Journal of Gastroenterology (Springer Nature) 89 (8), 1994
2001994
Clinical utility of anti-CCP antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica
M Lopez-Hoyos, C Ruiz de Alegria, R Blanco, J Crespo, M Pena, ...
Rheumatology 43 (5), 655-657, 2004
1932004
Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
JL Calleja, J Crespo, D Rincón, B Ruiz-Antorán, I Fernandez, C Perelló, ...
Journal of hepatology 66 (6), 1138-1148, 2017
1862017
The system can't perform the operation now. Try again later.
Articles 1–20